Acceleration of in vitro dissolution studies of sustained release dosage form of theophylline and in vitro-in vivo evaluations in terms of correlations

被引:1
|
作者
Ertan, Gokhan [1 ]
Karasulu, Ercument [2 ,3 ]
Ozguney, Isik [1 ]
Karasulu, Yesim [1 ]
Apaydin, Sebnem [3 ]
Kantarci, Gulten [4 ]
Yurdasiper, Aysu [1 ]
Ege, Mehmet Ali [1 ]
机构
[1] Ege Univ, Fac Pharm, Dept Pharmaceut Technol, TR-35100 Izmir, Turkey
[2] Ege Univ, Fac Pharm, Dept Biopharmacy & Pharmacokinet, TR-35100 Izmir, Turkey
[3] Ege Univ, Ctr Drug R&D & Pharmacokinet Applicat, TR-35100 Izmir, Turkey
[4] Ege Univ, Fac Pharm, Dept Pharmaceut Biotechnol, TR-35100 Izmir, Turkey
关键词
Theophylline; Sustained release; Accelerated release; Correlation; Similarity; PERCUTANEOUS-ABSORPTION; DRUG-RELEASE; FORMULATION; MICROSPHERES; PROFILES;
D O I
10.1007/s13318-011-0049-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of the study was to accelerate the dissolution of the sustained release dosage forms using both elevated temperature and high rpm rates. Teokap (R) SR 200 mg pellets were tested by in vitro sustained and accelerated dissolution studies using USP XXIII rotating paddle method. Sustained dissolution studies were carried out for 12 h in phosphate buffer at 37 +/- 0.5 degrees C and 50 rpm. Accelerated dissolution studies were performed for 48 min in distilled water at 90 +/- 1 degrees C and 250 rpm. The results obtained from accelerated and sustained dissolution studies were correlated using both linear and linear kinetic correlation methods by a computer program. While r(2) and maximum error between calculated and observed drug release rates were found to be 0.9129 and 15.9%, respectively, in linear correlation method, these values were observed as 0.9938 and 3.6%, respectively, in linear kinetic correlation method. In vivo plasma concentration data were obtained from six New Zealand rabbits after administration of a single dose of Teokap (R) SR 200 mg pellet. Then, the results of in vivo study were evaluated with in vitro accelerated and sustained dissolution results by applying them to in vitro-in vivo linear correlations. As a result of these correlations, it was shown that the in vitro correlation plots were very similar to the plot which was obtained by the in vivo study (f(2) = 73.81-77.11). This study suggested a way to prevent the loss of time for routine dissolution studies of sustained release preparations for quality control procedures using in vitro accelerated dissolution tests. The storage and quarantine periods of the product in process and process controls in the manufactories could be shortened by this method. Calculation of the in vivo performance of sustained release dosage forms using the results of the accelerated dissolution studies may be counted as another advantage of the method.
引用
收藏
页码:243 / 248
页数:6
相关论文
共 50 条
  • [21] Application of in vitro-in vivo correlations (IVIVC) in setting formulation release specifications
    Modi, NB
    Lam, A
    Lindemulder, E
    Wang, B
    Gupta, SK
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2000, 21 (08) : 321 - 326
  • [22] A multi-mechanistic drug release approach in a bead dosage form and in vitro/in vivo correlations
    Liu, Y
    Schwartz, JB
    Schnaare, RL
    Sugita, ET
    PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY, 2003, 8 (04) : 409 - 417
  • [23] Dosage form development, in vitro release kinetics, and in vitro-in vivo correlation for leuprolide released from an implantable multi-reservoir array
    Prescott, James H.
    Krieger, Timothy J.
    Lipka, Sara
    Staples, Mark A.
    PHARMACEUTICAL RESEARCH, 2007, 24 (07) : 1252 - 1261
  • [24] Studies on Core-Shell Nanocapsules of Felodipine: In Vitro-In Vivo Evaluations
    Jerome K. Geroge
    Priya Ranjan Prasad Verma
    Jayachandran Venkatesan
    Jin-Young Lee
    Dong-Han Yoon
    Se-Kwon Kim
    Sandeep Kumar Singh
    AAPS PharmSciTech, 2017, 18 : 2871 - 2888
  • [25] Studies on Core-Shell Nanocapsules of Felodipine: In Vitro-In Vivo Evaluations
    Geroge, Jerome K.
    Verma, Priya Ranjan Prasad
    Venkatesan, Jayachandran
    Lee, Jin-Young
    Yoon, Dong-Han
    Kim, Se-Kwon
    Singh, Sandeep Kumar
    AAPS PHARMSCITECH, 2017, 18 (08): : 2871 - 2888
  • [26] Pharmacokinetics of carbamazepine from extended release dosage forms:: bioavailability/bioequivalence and in vitro-in vivo correlation studies
    Koester, LS
    Dalla Costa, T
    Bassani, VL
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2004, 14 (05) : 401 - 407
  • [27] Manufacture and in vitro characterization of a new liquid theophylline sustained release dosage form - Sachets with microcapsules for the preparation of a ready-to-use sustained release suspension
    Weiss, G
    Klemm, FH
    Fuchs, WS
    Stanislaus, F
    Zema, M
    Calanchi, M
    ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 1998, 48 (5A): : 604 - 612
  • [28] In Vitro-In Vivo and In Vivo-In Vivo Correlations of TAF Release From a Novel Subdermal Implant
    Moss, John
    Gunawardana, Manjula
    Remedios-Chan, Mariana
    Sanchez, Debbie
    Webster, Simon
    Baum, Marc
    Weinberger, Dana
    Chatterji, Udayan
    Kuo, Joseph
    Gallay, Philippe
    Motamedi, Massoud
    Vincent, Kathleen
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 : 359 - 359
  • [29] Florfenicol sustained-release granules: an in vitro-in vivo correlation study in pigs
    Yang, Wei-cong
    Liu, Zi-yao
    Zhang, Yun-xiao
    Yu, Yang
    Shen, Yue
    Xu, Ying
    Huang, Xian-hui
    BMC VETERINARY RESEARCH, 2023, 19 (01)
  • [30] DEVELOPMENT AND IN VITRO-IN VIVO EVALUATION OF A MULTIPARTICULATE SUSTAINED-RELEASE FORMULATION OF DILTIAZEM
    LI, SP
    FELT, RG
    DIPAOLO, LC
    HUANG, MY
    WILLIAMS, RO
    PHARMACEUTICAL RESEARCH, 1995, 12 (09) : 1338 - 1342